NTLA Annual Current Ratio
8.67
-0.94-9.78%
31 December 2023
Summary:
As of January 20, 2025, NTLA annual current ratio is 8.67, with the most recent change of -0.94 (-9.78%) on December 31, 2023. During the last 3 years, it has fallen by -0.93 (-9.69%). NTLA annual current ratio is now -23.41% below its all-time high of 11.32, reached on December 31, 2017.NTLA Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NTLA Quarterly Current Ratio
6.73
-0.48-6.66%
30 September 2024
Summary:
As of January 20, 2025, NTLA quarterly current ratio is 6.73, with the most recent change of -0.48 (-6.66%) on September 30, 2024. Over the past year, it has dropped by -2.99 (-30.76%). NTLA quarterly current ratio is now -51.96% below its all-time high of 14.01, reached on June 30, 2016.NTLA Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NTLA Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.8% | -30.8% |
| 3 y3 years | -9.7% | -19.4% |
| 5 y5 years | +8.2% | -14.7% |
NTLA Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.8% | +41.9% | -30.8% | +10.2% |
| 5 y | 5-year | -9.8% | +41.9% | -32.0% | +10.2% |
| alltime | all time | -23.4% | +101.6% | -52.0% | +11.8% |
Intellia Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 6.73(-6.7%) |
| June 2024 | - | 7.21(-20.2%) |
| Mar 2024 | - | 9.03(+4.2%) |
| Dec 2023 | 8.67(-9.8%) | 8.67(-10.8%) |
| Sept 2023 | - | 9.72(+3.3%) |
| June 2023 | - | 9.41(+1.0%) |
| Mar 2023 | - | 9.32(-3.0%) |
| Dec 2022 | 9.61(+57.3%) | 9.61(+46.7%) |
| Sept 2022 | - | 6.55(-9.5%) |
| June 2022 | - | 7.24(+4.3%) |
| Mar 2022 | - | 6.94(+13.6%) |
| Dec 2021 | 6.11(-36.4%) | 6.11(-26.8%) |
| Sept 2021 | - | 8.35(+12.4%) |
| June 2021 | - | 7.43(-24.9%) |
| Mar 2021 | - | 9.90(+3.1%) |
| Dec 2020 | 9.60 | 9.60(+28.9%) |
| Sept 2020 | - | 7.45(-1.3%) |
| June 2020 | - | 7.55(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | 7.64(-5.9%) |
| Dec 2019 | 8.12(+1.4%) | 8.12(+2.9%) |
| Sept 2019 | - | 7.89(-1.3%) |
| June 2019 | - | 7.99(+3.2%) |
| Mar 2019 | - | 7.74(-3.4%) |
| Dec 2018 | 8.01(-29.2%) | 8.01(-30.5%) |
| Sept 2018 | - | 11.53(-8.6%) |
| June 2018 | - | 12.62(-4.4%) |
| Mar 2018 | - | 13.20(+16.6%) |
| Dec 2017 | 11.32(+23.7%) | 11.32(+27.5%) |
| Sept 2017 | - | 8.88(-4.8%) |
| June 2017 | - | 9.33(-11.0%) |
| Mar 2017 | - | 10.48(+14.5%) |
| Dec 2016 | 9.15(+26.0%) | 9.15(-29.2%) |
| Sept 2016 | - | 12.93(-7.7%) |
| June 2016 | - | 14.01(+132.7%) |
| Mar 2016 | - | 6.02(-17.1%) |
| Dec 2015 | 7.26(+68.8%) | 7.26 |
| Dec 2014 | 4.30 | - |
FAQ
- What is Intellia Therapeutics annual current ratio?
- What is the all time high annual current ratio for Intellia Therapeutics?
- What is Intellia Therapeutics annual current ratio year-on-year change?
- What is Intellia Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly current ratio year-on-year change?
What is Intellia Therapeutics annual current ratio?
The current annual current ratio of NTLA is 8.67
What is the all time high annual current ratio for Intellia Therapeutics?
Intellia Therapeutics all-time high annual current ratio is 11.32
What is Intellia Therapeutics annual current ratio year-on-year change?
Over the past year, NTLA annual current ratio has changed by -0.94 (-9.78%)
What is Intellia Therapeutics quarterly current ratio?
The current quarterly current ratio of NTLA is 6.73
What is the all time high quarterly current ratio for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly current ratio is 14.01
What is Intellia Therapeutics quarterly current ratio year-on-year change?
Over the past year, NTLA quarterly current ratio has changed by -2.99 (-30.76%)